Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Impact of Age on Predictive Capabilities of Ferritin, Ferritin-Hemoglobin Ratio, IL-6, and sIL-2R for COVID-19 Severity and Mortality

O. Skakun, Y. Vandzhura, I. Vandzhura, K. Symchych, A. Symchych

. 2024 ; 67 (2) : 53-59. [pub] -

Language English Country Czech Republic

Document type Journal Article

The study aimed to establish the impact of age on the predictive capability of ferritin, ferritin-hemoglobin ratio (FHR), IL-6, and sIL-2R in COVID-19 patients. Compared to patients with moderate condition, patients with severe condition had higher ferritin level (441.0 [188.0-829.8] ng/mL vs 281.0 [172.0-388.0] ng/mL, p = 0.002), sIL-2R level (6.0 [4.7-9.0] pg/mL vs 5.3 [3.7-6.9] pg/mL, p = 0.020), FHR (38.4 [15.1-63.4] vs 22.0 [12.1-32.1], p = 0.002). The area under the curves (AUC) for discriminative capabilities of the following biomarkers for severe condition were assessed in patients aged <65 years and patients aged ≥65 years: ferritin (AUC = 0.585, p = 0.309 vs AUC = 0.683, p = 0.002), FHR (AUC = 0.589, p = 0.302 vs AUC = 0.688, p = 0.002), IL-6 (AUC = 0.503, p = 0.972 vs AUC = 0.647, p = 0.019), and sIL-2R (AUC = 0.549, p = 0.552 vs AUC = 0.646, p = 0.017). Also AUCs for discriminative capabilities for in-hospital mortality were compared in patients aged <65 years and ≥65 years: ferritin (AUC = 0.607, p = 0.628 vs AUC = 0.661, p = 0.105), FHR (AUC = 0.612, p = 0.621 vs AUC = 0.688, p = 0.002), IL-6 (AUC = 0.580, p = 0.724 vs AUC = 0.695, p = 0.016), and sIL-2R (AUC = 0.620, p = 0.491 vs AUC = 0.695, p = 0.029). Thus, ferritin, FHR, IL-6, and sIL-2R didn't show acceptable predictive value for severe condition and lethal outcome in patients aged <65 years but had high predictive value for lethal outcome in patients aged ≥65 years.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24020964
003      
CZ-PrNML
005      
20250507135830.0
007      
ta
008      
241105s2024 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.14712/18059694.2024.20 $2 doi
035    __
$a (PubMed)39434671
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Skakun, Oleksii $u Clinic of St. Luka, Ivano-Frankivsk, Ukraine. olexiy109921@ukr.net
245    10
$a Impact of Age on Predictive Capabilities of Ferritin, Ferritin-Hemoglobin Ratio, IL-6, and sIL-2R for COVID-19 Severity and Mortality / $c O. Skakun, Y. Vandzhura, I. Vandzhura, K. Symchych, A. Symchych
520    9_
$a The study aimed to establish the impact of age on the predictive capability of ferritin, ferritin-hemoglobin ratio (FHR), IL-6, and sIL-2R in COVID-19 patients. Compared to patients with moderate condition, patients with severe condition had higher ferritin level (441.0 [188.0-829.8] ng/mL vs 281.0 [172.0-388.0] ng/mL, p = 0.002), sIL-2R level (6.0 [4.7-9.0] pg/mL vs 5.3 [3.7-6.9] pg/mL, p = 0.020), FHR (38.4 [15.1-63.4] vs 22.0 [12.1-32.1], p = 0.002). The area under the curves (AUC) for discriminative capabilities of the following biomarkers for severe condition were assessed in patients aged &lt;65 years and patients aged ≥65 years: ferritin (AUC = 0.585, p = 0.309 vs AUC = 0.683, p = 0.002), FHR (AUC = 0.589, p = 0.302 vs AUC = 0.688, p = 0.002), IL-6 (AUC = 0.503, p = 0.972 vs AUC = 0.647, p = 0.019), and sIL-2R (AUC = 0.549, p = 0.552 vs AUC = 0.646, p = 0.017). Also AUCs for discriminative capabilities for in-hospital mortality were compared in patients aged &lt;65 years and ≥65 years: ferritin (AUC = 0.607, p = 0.628 vs AUC = 0.661, p = 0.105), FHR (AUC = 0.612, p = 0.621 vs AUC = 0.688, p = 0.002), IL-6 (AUC = 0.580, p = 0.724 vs AUC = 0.695, p = 0.016), and sIL-2R (AUC = 0.620, p = 0.491 vs AUC = 0.695, p = 0.029). Thus, ferritin, FHR, IL-6, and sIL-2R didn't show acceptable predictive value for severe condition and lethal outcome in patients aged &lt;65 years but had high predictive value for lethal outcome in patients aged ≥65 years.
650    _2
$a lidé $7 D006801
650    12
$a COVID-19 $x mortalita $x krev $7 D000086382
650    12
$a ferritin $x krev $7 D005293
650    12
$a interleukin-6 $x krev $7 D015850
650    _2
$a senioři $7 D000368
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mužské pohlaví $7 D008297
650    12
$a biologické markery $x krev $7 D015415
650    _2
$a věkové faktory $7 D000367
650    12
$a stupeň závažnosti nemoci $7 D012720
650    _2
$a lidé středního věku $7 D008875
650    _2
$a hemoglobiny $x analýza $x metabolismus $7 D006454
650    _2
$a SARS-CoV-2 $7 D000086402
650    _2
$a receptory interleukinu-2 $x krev $7 D015375
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a senioři nad 80 let $7 D000369
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vandzhura, Yaroslava $u Ivano-Frankivsk National Medical University, Department of Internal Medicine #2 and Nursing, Ivano-Frankivsk, Ukraine
700    1_
$a Vandzhura, Ihor $u Ivano-Frankivsk National Medical University, Department of Internal Medicine #2 and Nursing, Ivano-Frankivsk, Ukraine
700    1_
$a Symchych, Khrystyna $u Ivano-Frankivsk National Medical University, Department of Therapy, Family and Emergency Medicine Postgraduate Education, Ivano-Frankivsk, Ukraine
700    1_
$a Symchych, Anton $u Ivano-Frankivsk National Medical University, Department of General and Vascular Surgery, Ivano-Frankivsk, Ukraine
773    0_
$w MED00010947 $t Acta Medica (Hradec Kralove) $x 1805-9694 $g Roč. 67, č. 2 (2024), s. 53-59
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39434671 $y Pubmed
910    __
$a ABA008 $b A 3077 $c 1072 $y p $z 0
990    __
$a 20241105 $b ABA008
991    __
$a 20250507135827 $b ABA008
999    __
$a ok $b bmc $g 2316507 $s 1232954
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 67 $c 2 $d 53-59 $e - $i 1805-9694 $m Acta medica (Hradec Kralove) $n Acta Medica (Hradec Kralove) $x MED00010947
LZP    __
$b NLK124 $a Pubmed-20241105

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...